10.12.2012 Views

Protein Protocols Protein Protocols

Protein Protocols Protein Protocols

Protein Protocols Protein Protocols

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

An Efficient Method for MAb Production 1137<br />

5. The myeloma cells should look uniform and healthy by this time with no sign of cell debris.<br />

6. We normally perform all steps up to this point in a separate sterile hood. The mouse is<br />

nonsterile externally, and particular care is taken to avoid hairs; the outer skin is torn,<br />

rather than cut, for this reason. Mice should not be introduced into the hood used for<br />

cell culture.<br />

7. Some protocols remove red blood cells by differential lysis at this point, but we have not<br />

found it necessary.<br />

8. The final concentration of PEG during fusion is thought to be critical for the yield of<br />

colonies. If initial yields are low, try adding increasing (but small) amounts of DMEM/<br />

25 mM HEPES to the pellet before adding PEG.<br />

9. Never use unplugged micropipet tips for adding to culture plates; sterile tips can be used<br />

for removing culture supernatant only.<br />

10. Bacterial and yeast contaminations rarely occur and are usually the result of a major failure<br />

in sterile technique (e.g., inadequate sterilization of culture medium or glassware).<br />

Sources of any sporadic fungal contamination should be tracked down and eliminated.<br />

11. Some protocols recommend freezing down uncloned or partly cloned cells as a precautionary<br />

measure. Following our rapid cloning protocol, however, the first round of cloning<br />

and screening is often complete before the original colony is sufficiently expanded<br />

for freezing. It is certainly advisable to keep the original culture alive, however, by adding<br />

0.1 mL of cloning medium back to the fusion well and by feeding the 24-well culture, if<br />

necessary. Cloning should not be regarded as an ordeal suitable only for healthy cells, but<br />

rather as a means of invigorating a failing culture. We always clone twice for this reason,<br />

even if the line is evidently clonal after the first round. As a general maxim: if in doubt or<br />

trouble, clone immediately.<br />

12. There are rare exceptions to the general principle that cloning should be continued until<br />

all colonies are positive in the screens. We were once performing an initial screen by<br />

ELISA and then testing ELISA-positive wells by immunofluorescence microscopy (IMF)<br />

on muscle sections. After cloning one well that was positive in both assays, we found that<br />

only half the clones were ELISA-positive and very few of these were also IMF-positive.<br />

We recloned wells that were positive in both assays again with the same result. We thought<br />

we had come across our first “unstable” hybridoma, but by chance we tested ELISAnegative<br />

wells in IMF and found they were all IMF-positive. Only then did we realize that<br />

the original fusion well had contained two different hybridomas, one ELISA-positive and<br />

one IMF-positive. The purpose of cloning is to separate such lines, but by selecting wells<br />

that were positive in both assays (and hence still had two clones), we had been systematically<br />

defeating this objective.<br />

13. When very few cells survive after being kept in liquid nitrogen, “cloning” by limiting<br />

dilution at about 100 total cells/well may be the only way to recover the cell line.<br />

14. Cells may also be collected by centrifugation and resuspended in 5% fetal calf serum at<br />

this stage, if a culture supernatant with low levels of nonmouse Ig is required.<br />

15. Most MAb are stable for long periods in sterile culture medium, but there are undoubtedly<br />

some that lose activity rapidly even at 4°C. These are perhaps best avoided, but, if required,<br />

bulk culture would have to be monitored regularly and supernatants harvested when their<br />

antibody activity is still high.<br />

Acknowledgment<br />

We thank C. J. Chesterton (King’s College, London) for sharing with us his enthusiasm<br />

for, and experience of, hybridoma technology in 1981.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!